Kirsten Lund-Jurgensen Net Worth & Insider Trades

Kirsten Lund-Jurgensen - Executive Vice President, Pfizer Inc

As of August 3, 2018

What is Kirsten Lund-Jurgensen's Net Worth?

The current estimated net worth of Pfizer Inc's Executive Vice President, Kirsten Lund-Jurgensen, is estimated to be about $2.55M . Kirsten Lund-Jurgensen owns about 4,643 units of Pfizer Inc common stock. In the last year at Pfizer Inc, Kirsten Lund-Jurgensen has sold an estimated value of $2.68M worth.

What is Kirsten Lund-Jurgensen's Past Insider Trading?

Kirsten Lund-Jurgensen's largest purchase order was 15,957 units , worth over $301.59K on February 27, 2018. Kirsten Lund-Jurgensen's largest sale order was 20,942 units , worth over $838.57K on August 3, 2018. In total, Kirsten Lund-Jurgensen has made about 8 transactions over a year of their time at Pfizer Inc. Kirsten Lund-Jurgensen usually trades in February, with the busiest year in 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Kirsten Lund-Jurgensen's' Mailing Address?

  • Mailing address is C/o Pfizer Inc. 235 East 42nd Street New York NY 10017 NY

Pfizer Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
A. Bourla 2020 $1,650,000 - $4,897,817 $6,782,951 $5,491,800 $1,367,780 $843,222 $21,033,570
A. Bourla 2019 $1,600,000 - $4,290,956 $6,075,290 $3,630,000 $1,726,448 $606,269 $17,928,963
A. Bourla 2018 $1,400,000 - $2,592,079 $3,954,369 $1,533,000 $0 $375,109 $9,854,557
F. D’Amelio 2020 $1,533,750 - $2,406,437 $3,130,596 $2,470,000 $1,318,297 $517,016 $11,376,096
F. D’Amelio 2019 $1,500,000 - $2,582,446 $3,037,649 $1,820,000 $1,612,163 $523,472 $11,075,730
F. D’Amelio 2018 $1,407,917 - $2,013,091 $2,108,995 $1,310,000 $0 $299,826 $7,139,829
M. Dolsten 2020 $1,433,750 - $2,110,585 $2,608,832 $2,600,000 $928,638 $467,819 $10,149,624
M. Dolsten 2019 $1,400,000 - $2,414,725 $2,531,376 $1,820,000 $987,243 $444,701 $9,598,045
M. Dolsten 2018 $1,306,250 - $2,013,091 $2,108,995 $1,326,000 $0 $315,863 $7,070,199
A. Hwang 2020 $1,142,500 - $1,420,129 $2,087,062 $2,387,800 $405,242 $440,714 $7,883,447
J. Young 2020 $1,285,000 - $1,814,734 $2,087,062 $1,800,000 $1,551,403 $450,994 $8,989,193
J. Young 2019 $1,245,000 - $2,247,004 $2,025,093 $1,675,000 $1,325,847 $441,439 $8,959,383
J. Young 2018 $1,206,250 - $2,013,091 $2,108,995 $1,385,000 $0 $408,379 $7,121,715
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/78003/000007800321000047/proxystatement.htm

What are Pfizer Inc's Past Insider Trades?

Pfizer Inc's most recent insider trade came on June 8, 2022 by Jennifer B Damico who sold 4,218 units worth $227.6K . In the last 19 years, insiders at Pfizer Inc have sold an estimated value of $956.55M and bought an estimated value of $479.03M worth of shares. Insider trading is most common in April, with the busiest year in 2013. The most active traders at the company are Loretta V Cangialosi, Sr. Vice President,  Ian C Read, Executive Chairman,  and Albert Bourla, Chairman & CEO .

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1